No Link Between Sun Exposure and Lymphoma

Researchers from Sweden and Denmark have reported that ultraviolet (UV) exposure does not increase the incidence of malignant lymphomas, but instead is associated with a lower incidence of non-Hodgkin’s lymphoma (NHL). The incidence of malignant lymphoma has been increasing over the past several decades in the US population. The reasons for this increase are unknown. In fact, the causes of most lymphomas are unknown, except for the relatively few that are associated with specific bacteria (Helicobacter pylori in gastric lymphoma), or viruses such as the Epstein-Barr virus (Burkitt’s lymphoma), HIV-related lymphomas, body cavity lymphomas (human herpes virus-8) or T-cell lymphoma (HTLV-1). However, none of these specific causes explains the increased incidence of lymphomas observed in recent years.

There is speculation that exposure to chemicals, such as certain solvents, pesticides, herbicides, and water contaminated with nitrate, are responsible for the increased incidence of lymphomas. Another speculation is that the increased incidence of lymphomas is due to an increase in sun exposure.

Researchers carrying out the current study looked at sun exposure in 3,740 patients with non-Hodgkin’s lymphoma, Hodgkin’s lymphoma or chronic lymphocytic leukemia and 3,187 individuals without lymphoma. They found that different types of sun exposure were associated with a decreased incidence of NHL. The types of sun exposure associated with a 30-40% decrease in the incidence of NHL included high frequency of sun bathing, sun vacations and sunburns.

Sun exposure is linked to other types of cancer, though and sunscreen and protective clothing is still a safe bet.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap